The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
Open accessAbstract
The pharmacological inhibition of general transcriptional regulators has the potential to block growth through targeting multiple tumorigenic signalling pathways simultaneously. Here, using an innovative cell-based screen, we identify a structurally unique small molecule (named JIB-04) that specifically inhibits the activity of the Jumonji family of histone demethylases in vitro, in cancer cells, and in tumours in vivo. Unlike known inhibitors, JIB-04 is not a competitive inhibitor of α-ketoglutarate. In cancer, but not in patient-matched normal cells, JIB-04 alters a subset of transcriptional pathways and blocks viability. In mice, JIB-04 reduces tumour burden and prolongs survival. Importantly, we find that patients with breast tumours that overexpress Jumonji demethylases have significantly lower survival. Thus, JIB-04, a novel inhibitor of Jumonji demethylases in vitro and in vivo, constitutes a unique potential therapeutic and research tool against cancer, and validates the use of unbiased cellular screens to discover chemical modulators with disease relevance. Epigenetic regulators are promising targets for cancer drugs, as they can modulate a broad range of transcriptional networks simultaneously. Here, the authors identify an inhibitor of Jumonji-family histone demethylases and show that it selectively kills cancer cells in mouse tumour models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers
Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2876 · Cited by 1,099
Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases
Whetstine, J. R., Nottke, A., Lan, F., Huarte, M., Smolikov, S., Chen, Z., Spooner, E., Li, E., Zhang, G., Colaiacovo, M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.028 · Cited by 1,040
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
Kruidenier, L., Chung, C.-W., Cheng, Z., Liddle, J., Che, K., Joberty, G., Bantscheff, M., Bountra, C., Bridges, A., Diallo, H., et al. (2012) · Nature · doi:10.1038/nature11262 · Cited by 950
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3
Cloos, P. A. C., Christensen, J., Agger, K., Maiolica, A., Rappsilber, J., Antal, T., Hansen, K. H., & Helin, K. (2006) · Nature · doi:10.1038/nature04837 · Cited by 736
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
Ramirez, R. D., Sheridan, S., Girard, L., Sato, M., Kim, Y., Pollack, J., Peyton, M., Zou, Y., Kurie, J. M., DiMaio, J. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3703 · Cited by 607
Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases
Mosammaparast, N., & Shi, Y. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.070907.103946 · Cited by 585
Grozinger, C. M., Chao, E. D., Blackwell, H. E., Moazed, D., & Schreiber, S. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106779200 · Cited by 539
Role of Jhdm2a in regulating metabolic gene expression and obesity resistance
Tateishi, K., Okada, Y., Kallin, E. M., & Zhang, Y. (2009) · Nature · doi:10.1038/nature07777 · Cited by 440
High‐Throughput Real‐Time Quantitative Reverse Transcription PCR
Bookout, A. L., Cummins, C. L., Mangelsdorf, D. J., Pesola, J. M., & Kramer, M. F. (2006) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1508s73 · Cited by 398
Structural Insights into Histone Demethylation by JMJD2 Family Members
Chen, Z., Zang, J., Whetstine, J., Hong, X., Davrazou, F., Kutateladze, T. G., Simpson, M., Mao, Q., Pan, C.-H., Dai, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.04.024 · Cited by 395
Inhibition of 2-oxoglutarate dependent oxygenases
Rose, N. R., McDonough, M. A., King, O. N. F., Kawamura, A., & Schofield, C. J. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00203h · Cited by 390
Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity
Ng, S. S., Kavanagh, K. L., McDonough, M. A., Butler, D., Pilka, E. S., Lienard, B. M. R., Bray, J. E., Savitsky, P., Gileadi, O., von Delft, F., et al. (2007) · Nature · doi:10.1038/nature05971 · Cited by 325
Huang, Y., Greene, E., Murray Stewart, T., Goodwin, A. C., Baylin, S. B., Woster, P. M., & Casero, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700720104 · Cited by 292
Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase
Couture, J.-F., Collazo, E., Ortiz-Tello, P. A., Brunzelle, J. S., & Trievel, R. C. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1273 · Cited by 274
Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases
Rose, N. R., Ng, S. S., Mecinović, J., Liénard, B. M. R., Bello, S. H., Sun, Z., McDonough, M. A., Oppermann, U., & Schofield, C. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800936s · Cited by 250
Zhang, Q.-J., Chen, H.-Z., Wang, L., Liu, D.-P., Hill, J. A., & Liu, Z.-P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46277 · Cited by 226
Self-citationKing, O. N. F., Li, X. S., Sakurai, M., Kawamura, A., Rose, N. R., Ng, S. S., Quinn, A. M., Rai, G., Mott, B. T., Beswick, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015535 · Cited by 223
Self-citationIsoform-specific histone deacetylase inhibitors: The next step?
Balasubramanian, S., Verner, E., & Buggy, J. J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.013 · Cited by 220
Roland, C. L., Lynn, K. D., Toombs, J. E., Dineen, S. P., Udugamasooriya, D. G., & Brekken, R. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007669 · Cited by 207
Self-citationHayami, S., Yoshimatsu, M., Veerakumarasivam, A., Unoki, M., Iwai, Y., Tsunoda, T., Field, H. I., Kelly, J. D., Neal, D. E., Yamaue, H., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-59 · Cited by 207
Li, Q., Shi, L., Gui, B., Yu, W., Wang, J., Zhang, D., Han, X., Yao, Z., & Shang, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1523 · Cited by 190
Yang, J., Jubb, A. M., Pike, L., Buffa, F. M., Turley, H., Baban, D., Leek, R., Gatter, K. C., Ragoussis, J., & Harris, A. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0413 · Cited by 182
Structural insights into histone lysine demethylation
Hou, H., & Yu, H. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.09.006 · Cited by 178
Hamada, S., Suzuki, T., Mino, K., Koseki, K., Oehme, F., Flamme, I., Ozasa, H., Itoh, Y., Ogasawara, D., Komaarashi, H., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1003655 · Cited by 162
Genome‐wide histone methylation profile for heart failure
Kaneda, R., Takada, S., Yamashita, Y., Choi, Y. L., Nonaka‐Sarukawa, M., Soda, M., Misawa, Y., Isomura, T., Shimada, K., & Mano, H. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01252.x · Cited by 161
Conserved Antagonism between JMJD2A/KDM4A and HP1γ during Cell Cycle Progression
Black, J. C., Allen, A., Rechem, C. V., Forbes, E. K., Longworth, M. S., Tschöp, K., Rinehart, C. A., Quiton, J., Walsh, R. M., Smallwood, A., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.008 · Cited by 157
Luo, Y., Knuckley, B., Lee, Y., Stallcup, M. R., & Thompson, P. R. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0576233 · Cited by 153
Selective Inhibition of c-Myc/Max Dimerization and DNA Binding by Small Molecules
Kiessling, A., Sperl, B., Hollis, A., Eick, D., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.011 · Cited by 153
Rose, N. R., Woon, E. C. Y., Kingham, G. L., King, O. N. F., Mecinović, J., Clifton, I. J., Ng, S. S., Talib-Hardy, J., Oppermann, U. C. T., McDonough, M. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901680b · Cited by 148
Target-Based Approach to Inhibitors of Histone Arginine Methyltransferases
Spannhoff, A., Heinke, R., Bauer, I., Trojer, P., Metzger, E., Gust, R., Schüle, R., Brosch, G., Sippl, W., & Jung, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061250e · Cited by 148
jumonji Downregulates Cardiac Cell Proliferation by Repressing cyclin D1 Expression
Toyoda, M., Shirato, H., Nakajima, K., Kojima, M., Takahashi, M., Kubota, M., Suzuki-Migishima, R., Motegi, Y., Yokoyama, M., & Takeuchi, T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00189-8 · Cited by 131
Bissinger, E.-M., Heinke, R., Spannhoff, A., Eberlin, A., Metzger, E., Cura, V., Hassenboehler, P., Cavarelli, J., Schüle, R., Bedford, M. T., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.032 · Cited by 112
A miniaturized screen for inhibitors of Jumonji histonedemethylases
Sakurai, M., Rose, N. R., Schultz, L., Quinn, A. M., Jadhav, A., Ng, S. S., Oppermann, U. C. T., Schofield, C. J., & Simeonov, A. M. (2009) · Molecular BioSystems · doi:10.1039/b912993f · Cited by 92
Self-citationHigh‐Throughput Real‐Time Quantitative Reverse Transcription PCR
Bookout, A. L., Cummins, C. L., & Mangelsdorf, D. J. (2005) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1508s71 · Cited by 91
Histone Demethylase JHDM2A Is Involved in Male Infertility and Obesity
Okada, Y., Tateishi, K., & Zhang, Y. (2010) · Journal of Andrology · doi:10.2164/jandrol.109.008052 · Cited by 86
Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer
Jeong, Y., Xie, Y., Xiao, G., Behrens, C., Girard, L., Wistuba, I. I., Minna, J. D., & Mangelsdorf, D. J. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000378 · Cited by 76
Holbeck, S. L., Chang, J., Best, A. M., Bookout, A. L., Mangelsdorf, D. J., & Martinez, E. D. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0040 · Cited by 71
Self-citationNovel Structural Insights into Class I and II Histone Deacetylases
Ficner, R. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609788085304 · Cited by 71
Inhibition of the histone demethylase JMJD2E by 3-substituted pyridine 2,4-dicarboxylates
Thalhammer, A., Mecinović, J., Loenarz, C., Tumber, A., Rose, N. R., Heightman, T. D., & Schofield, C. J. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00592d · Cited by 60
Mackeen, M. M., Kramer, H., Chang, K.-H., Coleman, M. L., Hopkinson, R. J., Schofield, C. J., & Kessler, B. M. (2010) · Journal of Proteome Research · doi:10.1021/pr100269b · Cited by 59
An Analog of BIX-01294 Selectively Inhibits a Family of Histone H3 Lysine 9 Jumonji Demethylases
Upadhyay, A. K., Rotili, D., Han, J. W., Hu, R., Chang, Y., Labella, D., Zhang, X., Yoon, Y., Mai, A., & Cheng, X. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.036 · Cited by 58
Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10
Kim, J., Shin, S., Subramaniam, M., Bruinsma, E. S., Kim, T., Hawse, J. R., Spelsberg, T. C., & Janknecht, R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.068 · Cited by 58
Chapter 4 Histone Demethylases and Cancer
Kampranis, S. C., & Tsichlis, P. N. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)02004-1 · Cited by 56
NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia
Breccia, M., & Alimena, G. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.522570 · Cited by 50
Easmon, J., Heinisch, G., Pürstinger, G., Langer, T., Österreicher, J. K., Grunicke, H. H., & Hofmann, J. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970255w · Cited by 48
Self-citationA quantitative high-throughput screen identifies potential epigenetic modulators of gene expression
Johnson, R. L., Huang, W., Jadhav, A., Austin, C. P., Inglese, J., & Martínez, E. D. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.12.028 · Cited by 37
Transcriptional and epigenetic networks in haematological malignancy
Cheung, N., & So, C. W. E. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.068 · Cited by 36
Small Molecule Inhibitors as Probes for Estrogen and Androgen Receptor Action
Shapiro, D. J., Mao, C., & Cherian, M. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.203026 · Cited by 35
Auld, D. S., Johnson, R. L., Zhang, Y., Veith, H., Jadhav, A., Yasgar, A., Simeonov, A. M., Zheng, W., Martinez, E. D., Westwick, J. K., et al. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)14029-x · Cited by 29
Self-citationHigh‐Content Fluorescence‐Based Screening for Epigenetic Modulators
Martínez, E. D., Dull, A. B., Beutler, J. A., & Hager, G. L. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)14002-1 · Cited by 28
Mulji, A., Haslam, C. P., Brown, F., Randle, R. A., Karamshi, B., Smith, J. E., Eagle, R., Muñoz, J. A., Taylor, J., Sheikh, A., et al. (2012) · SLAS DISCOVERY · doi:10.1177/1087057111418229 · Cited by 20
Cited by
Role of RNA modifications in cancer
Barbieri, I., & Kouzarides, T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0253-2 · Cited by 1,312
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Huang, Y., Su, R., Sheng, Y., Dong, L., Dong, Z., Xu, H., Ni, T., Zhang, Z. S., Zhang, T., Li, C., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.006 · Cited by 877
Nava, M. M., Miroshnikova, Y. A., Biggs, L. C., Whitefield, D. B., Metge, F., Boucas, J., Vihinen, H., Jokitalo, E., Li, X., García Arcos, J. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.052 · Cited by 646
Histone lysine demethylases as targets for anticancer therapy
Højfeldt, J. W., Agger, K., & Helin, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4154 · Cited by 455
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Hamamoto, R., Saloura, V., & Nakamura, Y. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3884 · Cited by 376
Metadata
- Authors
- Wang, L., Chang, J., Varghese, D., Dellinger, M., Kumar, S., Best, A. M., Ruiz, J., Bruick, R., Peña-Llopis, S., Xu, J., Babinski, D. J., Frantz, D. E., Brekken, R. A., Quinn, A. M., Simeonov, A., Easmon, J., & Martinez, E. D.
- Venue
- Nature Communications
- Published
- 2013-06-24
- Volume
- 4
- Issue
- 1
- Pages
- 2035-2035
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2056842797
- Cited by
- 316
- References
- 54
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.